X射线与γ射线技术整合的格点放疗优化大体积非小细胞肺癌剂量递送
这项回顾性研究为10例大体积非小细胞肺癌(GTV 572–1367 cm³)设计格点放疗(LRT),比较TaiChiB双模态系统与常规Linac计划的剂量学差异。结果显示TaiChiB显著提高瘤内顶点剂量与峰谷剂量比,并降低GTV边缘及危及器官剂量,提示该整合平台用于大体积肺肿瘤LRT可行。
要点
- 10例大体积NSCLC(GTV均值862.9 cm³)行LRT,单次12 Gy至瘤内顶点后常规分割放疗。
- TaiChiB较Linac显著提高GTV内D0.5 cc、Dmean与EQD2(P<0.01)。
- TaiChiB提高PVDR并降低右肺、心脏、食管、脊髓剂量,全部计划满足OAR约束。
核心结论
- 整合X射线与γ射线的平台可提高GTV内顶点剂量,同时降低GTV边缘和危及器官剂量,为大体积肺肿瘤LRT提供可行且有前景的方法。
研究设计与样本
- 回顾性研究,为10例GTV 572–1367 cm³(均值862.9±285.4 cm³)的非小细胞肺癌病例设计格点放疗。
- 每例LRT计划含单次12 Gy至瘤内顶点,随后常规外照射25次、每次1.8 Gy至PTV。
- Linac计划用Varian Eclipse 13.5 TPS生成,TaiChiB系统计划用RT PRO TPS生成(聚焦γ计划靶向顶点,Linac计划覆盖PTV)。
- 比较D0.5 cc、D10/D90、EQD2与Dmean等剂量学指标。
主要发现
- 每例植入中位8.5个高剂量顶点(范围6–13),顶点直径1.5 cm、间距3–3.5 cm。
- 顶点平均体积17.2±4.5 cm³,占GTV的2.05%±0.34%。
- 与Linac计划相比,TaiChiB计划GTV内D0.5 cc、Dmean和EQD2显著升高(P<0.01),PVDR(D10/D90)显著改善(P<0.01),GTV边缘剂量降低。
- TaiChiB计划显著降低右肺Dmean(P=0.031)、心脏Dmean(P=0.024)、食管Dmax(P<0.01)和脊髓Dmax(P=0.042)。
- 所有计划均符合OAR剂量约束,保证临床可行性与患者安全。
关键数值与推荐
- LRT顶点处方:单次12 Gy。
- 常规外照射:25次×1.8 Gy至PTV。
- 顶点参数:直径1.5 cm,间距3–3.5 cm,中位8.5个(范围6–13)。
- 剂量学比较指标:D0.5 cc、D10/D90、EQD2、Dmean及OAR剂量约束。
临床怎么用
- 对大体积NSCLC行LRT时,可考虑双模态平台以在提高瘤内顶点剂量的同时更好保护GTV边缘和OAR。
- 计划评估应关注PVDR(D10/D90)、GTV内D0.5 cc与Dmean,以及右肺、心脏、食管、脊髓的剂量约束。
局限性
- 回顾性研究,样本量为10例。
- 研究为剂量学比较,未报告临床疗效或毒性结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Leveraging the distinct properties of X-rays and γ-rays, a novel radiation therapy platform integrating both modalities has been implemented in clinical practice (NMPA: 20223050973; FDA: K210921). This study investigates the application of this integrated approach in spatially fractionated radiotherapy, systematically evaluating its feasibility and therapeutic potential. METHODS: In this retrospective study, lattice radiotherapy (LRT) was designed for 10 NSCLC cases with gross tumor volumes (GTV) ranging from 572 to 1367 cm³ (mean 862.9 ± 285.4 cm³), incorporating the number of high-dose vertices per case ranged from 6 to 13, with a median of 8.5, respectively. Each LRT plan consisted of a single 12 Gy dose to the intratumoral vertices, followed by conventional external beam radiotherapy (cEBRT) delivering 25 daily fractions of 1.8 Gy to the Planning Target Volume (PTV). Treatment plans were developed using the Varian Eclipse 13.5 Treatment Planning System (TPS) for Linac plans, while TaiChiB system plans were generated using the RT PRO TPS: a focused gamma plan was created to target the vertices, and a Linac plan was optimized to cover the PTV. A comparative analysis of D0.5 cc, D10/D90, EQD2, and Dmean was performed to evaluate the ability of dual-modality to optimize high-dose vertices while reducing doses to GTV margins and organs at risk (OARs). RESULTS: The LRT plan involved the placement of a median of 8.5 high-dose vertices (range, 6 to13), each with a diameter of 1.5 cm and spaced 3-3.5 cm apart within the GTV. The average vertices volume was 17.2 ± 4.5 cm³, corresponding to 2.05% ± 0.34% of the GTV. Compared to the Linac plans, the TaiChiB system plans demonstrated significantly increased D0.5 cc, Dmean, and EQD2 within the GTV (P < 0.01), improved peak/valley dose ratio (PVDR, D10/D90, P < 0.01), and reduced marginal GTV dose. Additionally, the TaiChiB system plans significantly reduced doses to OARs, including right lung Dmean (P = 0.031), heart Dmean (P = 0.024), esophagus Dmax (P < 0.01), and spinal cord Dmax (P = 0.042). All plans complied with the OARs dose constraints, thereby ensuring clinical feasibility and patient safety. CONCLUSION: By integrating X-ray and γ-ray technologies, this platform enhances the vertex dose within the GTV while reducing doses to the GTV margins and OARs, offering a promising and feasible approach for the treatment of LRT in patients with large-volume lung tumors.
引用
- Gao Y, Yun Q, An Z, et al. Integration of X-Ray and γ-Ray technologies in lattice radiotherapy: a novel approach for optimizing dose delivery in large-volume non-small cell lung cancer. Radiat Oncol. 2025. PMID: 41327273. doi:10.1186/s13014-025-02757-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。